Mesenchymal stem cells-derived extracellular vesicles as natural drug delivery system for tissue regeneration

Research output: Contribution to journalArticlepeer-review


Mesenchymal stem cells (MSCs) have abilities to mediate tissue protection through mechanisms of antiapoptosis, anti-oxidative stress and anti-fibrosis as well as tissue regeneration through mechanisms of cell proliferation, differentiation and angiogenesis. These effects by MSCs are mediated by a variety of factors, including growth factors, cytokines and extracellular vesicles (EVs). Among these factors, EVs, containing proteins, mRNA and microRNAs (miRNA), may carry their contents into distant tissues with high stability. Therefore, the treatment with MSC-derived EVs may be promising as natural drug delivery systems (DDS). Especially, the treatment of MSCderived EVs with the manipulation of specific miRNAs expression has been reported to be beneficial under a variety of diseases and tissue injuries. The overexpression of specific miRNAs in the EVs might be through pre-loading method using the gene editing system by plasmid vector or post-loading method to load miRNA mimics into EVs by electroporation or calcium chloride-mediated transfection. Despite current several challenges for clinical use, it should open the next era of regenerative medicine for a variety of diseases. In this article, we highlight the therapeutic potential of MSC-derived EVs as natural DDS and current challenges.

Original languageEnglish
Pages (from-to)899-902
Number of pages4
Issue number4
Publication statusPublished - 2022


  • Drug delivery system
  • Extracellular vesicles
  • Mesenchymal stem cells
  • microRNA
  • Regeneration

ASJC Scopus subject areas

  • Cell Biology


Dive into the research topics of 'Mesenchymal stem cells-derived extracellular vesicles as natural drug delivery system for tissue regeneration'. Together they form a unique fingerprint.

Cite this